Alcoholic Hepatitis clinical trials at UCSF

1 in progress, 0 open to eligible people

Alcoholic Hepatitis to Evaluate Safety and Efficacy of DUR-928 Treatment
Sorry, in progress, not accepting new patients
This is a randomized, double-blind, placebo-controlled, phase 2b clinical Trial evaluating Safety and Efficacy of DUR-928 (an experimental medication) in Patients with Alcoholic Hepatitis (AH).
San Francisco, California and other locations

Last updated: June 2023